Document Detail


Activation of molecular oxygen by a metal-organic framework with open 2,2'-bipyridine for selective oxidation of saturated hydrocarbons.
MedLine Citation:
PMID:  23139936     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
A metal-organic framework with open 2,2'-bipyridine sites can efficiently activate molecular oxygen for selective oxidation of a variety of saturated hydrocarbons with unprecedented activities and selectivities.
Authors:
Jilan Long; Liming Wang; Xingfa Gao; Cuihua Bai; Huanfeng Jiang; Yingwei Li
Related Documents :
18616336 - Electronic modulation of fused oligothiophenes by chemical oxidation.
23630136 - Tandem synthesis of photoactive benzodifuran moieties in the formation of microporous o...
17064006 - Radical-molecule reactions for aromatic growth: a case study for cyclopentadienyl and a...
21151736 - A new route to silyl-substituted cyclobutenones and silylketenes.
12045326 - Improvement of a biomimetic porphyrin catalytic system by addition of acids.
15225696 - A convenient and biogenetic type synthesis of few naturally occurring chromeno dihydroc...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-8
Journal Detail:
Title:  Chemical communications (Cambridge, England)     Volume:  -     ISSN:  1364-548X     ISO Abbreviation:  Chem. Commun. (Camb.)     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610838     Medline TA:  Chem Commun (Camb)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
The Key Lab of Enhanced Heat Transfer and Energy Conservation, Ministry of Education, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510640, China. liyw@scut.edu.cn.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A multimodal, ?-amyloid-targeted contrast agent.
Next Document:  Veterans' Group Life Insurance (VGLI) no-health period extension. Final rule.